Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice
Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6...
Gespeichert in:
Veröffentlicht in: | The Journal of nuclear medicine (1978) 2017-05, Vol.58, p.1101 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 1101 |
container_title | The Journal of nuclear medicine (1978) |
container_volume | 58 |
creator | Li, Ming-Hsin Shiue, Chyng-Yann Chang, Han-Chih Feng, Chun-Fang Chang, Chih-Hsien |
description | Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6,8 protein and SAMR1/SAMP/8 rodent animal model) is described for the first time. The radio synthesis has been approached by reaction of the non-radioactive precursor N-(4-amino-[1,1'-biphenyl]-3-yl)-4-((dimethylamino)methyl)benzamide with [18F] flouride in basic media. Results: Despite the presence of more than one reactive site in the chemical structure of the precursor, acceptable radiochemical yield (3%, decay corrected to the end of bombardment), specific activity ( 100±25 μCi/ 100μL ) and radio chemical purity values (95%) were obtained in reasonably short preparation times(40 min). Conclusion: Despite the moderate radio chemical yield, final radioactivity and radioactivity concentration values (1.870.3GBq and 180MBq/ml, respectively) should be sufficient for putative in vivo studies in animals. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2039865117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2039865117</sourcerecordid><originalsourceid>FETCH-proquest_journals_20398651173</originalsourceid><addsrcrecordid>eNqNyr0KwjAUQOEgCtafd7jgHEgsN4ljqS120EHdS9C0ptREm1bw7XXwAZzO8J0RiTjGSFEIOSYR44JTRIZTMguhYYwJpVREitPb9TcTbADtrmBeuh10b70DX0FOuaLFITtSjlKCDrDbJqmF4q5r62pIauN6sA729mIWZFLpNpjlr3OyyrNzuqOPzj8HE_qy8UPnvlSuWbxRAjmX8X_XB-l5Ojw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2039865117</pqid></control><display><type>article</type><title>Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Li, Ming-Hsin ; Shiue, Chyng-Yann ; Chang, Han-Chih ; Feng, Chun-Fang ; Chang, Chih-Hsien</creator><creatorcontrib>Li, Ming-Hsin ; Shiue, Chyng-Yann ; Chang, Han-Chih ; Feng, Chun-Fang ; Chang, Chih-Hsien</creatorcontrib><description>Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6,8 protein and SAMR1/SAMP/8 rodent animal model) is described for the first time. The radio synthesis has been approached by reaction of the non-radioactive precursor N-(4-amino-[1,1'-biphenyl]-3-yl)-4-((dimethylamino)methyl)benzamide with [18F] flouride in basic media. Results: Despite the presence of more than one reactive site in the chemical structure of the precursor, acceptable radiochemical yield (3%, decay corrected to the end of bombardment), specific activity ( 100±25 μCi/ 100μL ) and radio chemical purity values (95%) were obtained in reasonably short preparation times(40 min). Conclusion: Despite the moderate radio chemical yield, final radioactivity and radioactivity concentration values (1.870.3GBq and 180MBq/ml, respectively) should be sufficient for putative in vivo studies in animals.</description><identifier>ISSN: 0161-5505</identifier><identifier>EISSN: 1535-5667</identifier><language>eng</language><publisher>New York: Society of Nuclear Medicine</publisher><subject>Benzamide ; Biphenyl ; Bombardment ; Cancer ; Chemical synthesis ; Histone deacetylase ; In vivo methods and tests ; Neurological diseases ; Neurological disorders ; Nuclear medicine ; Organic chemistry ; Precursors ; Proteins ; Radioactivity ; Radiochemistry ; Therapeutic applications</subject><ispartof>The Journal of nuclear medicine (1978), 2017-05, Vol.58, p.1101</ispartof><rights>Copyright Society of Nuclear Medicine May 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Li, Ming-Hsin</creatorcontrib><creatorcontrib>Shiue, Chyng-Yann</creatorcontrib><creatorcontrib>Chang, Han-Chih</creatorcontrib><creatorcontrib>Feng, Chun-Fang</creatorcontrib><creatorcontrib>Chang, Chih-Hsien</creatorcontrib><title>Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice</title><title>The Journal of nuclear medicine (1978)</title><description>Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6,8 protein and SAMR1/SAMP/8 rodent animal model) is described for the first time. The radio synthesis has been approached by reaction of the non-radioactive precursor N-(4-amino-[1,1'-biphenyl]-3-yl)-4-((dimethylamino)methyl)benzamide with [18F] flouride in basic media. Results: Despite the presence of more than one reactive site in the chemical structure of the precursor, acceptable radiochemical yield (3%, decay corrected to the end of bombardment), specific activity ( 100±25 μCi/ 100μL ) and radio chemical purity values (95%) were obtained in reasonably short preparation times(40 min). Conclusion: Despite the moderate radio chemical yield, final radioactivity and radioactivity concentration values (1.870.3GBq and 180MBq/ml, respectively) should be sufficient for putative in vivo studies in animals.</description><subject>Benzamide</subject><subject>Biphenyl</subject><subject>Bombardment</subject><subject>Cancer</subject><subject>Chemical synthesis</subject><subject>Histone deacetylase</subject><subject>In vivo methods and tests</subject><subject>Neurological diseases</subject><subject>Neurological disorders</subject><subject>Nuclear medicine</subject><subject>Organic chemistry</subject><subject>Precursors</subject><subject>Proteins</subject><subject>Radioactivity</subject><subject>Radiochemistry</subject><subject>Therapeutic applications</subject><issn>0161-5505</issn><issn>1535-5667</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNyr0KwjAUQOEgCtafd7jgHEgsN4ljqS120EHdS9C0ptREm1bw7XXwAZzO8J0RiTjGSFEIOSYR44JTRIZTMguhYYwJpVREitPb9TcTbADtrmBeuh10b70DX0FOuaLFITtSjlKCDrDbJqmF4q5r62pIauN6sA729mIWZFLpNpjlr3OyyrNzuqOPzj8HE_qy8UPnvlSuWbxRAjmX8X_XB-l5Ojw</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Li, Ming-Hsin</creator><creator>Shiue, Chyng-Yann</creator><creator>Chang, Han-Chih</creator><creator>Feng, Chun-Fang</creator><creator>Chang, Chih-Hsien</creator><general>Society of Nuclear Medicine</general><scope>4T-</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20170501</creationdate><title>Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice</title><author>Li, Ming-Hsin ; Shiue, Chyng-Yann ; Chang, Han-Chih ; Feng, Chun-Fang ; Chang, Chih-Hsien</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_20398651173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Benzamide</topic><topic>Biphenyl</topic><topic>Bombardment</topic><topic>Cancer</topic><topic>Chemical synthesis</topic><topic>Histone deacetylase</topic><topic>In vivo methods and tests</topic><topic>Neurological diseases</topic><topic>Neurological disorders</topic><topic>Nuclear medicine</topic><topic>Organic chemistry</topic><topic>Precursors</topic><topic>Proteins</topic><topic>Radioactivity</topic><topic>Radiochemistry</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Ming-Hsin</creatorcontrib><creatorcontrib>Shiue, Chyng-Yann</creatorcontrib><creatorcontrib>Chang, Han-Chih</creatorcontrib><creatorcontrib>Feng, Chun-Fang</creatorcontrib><creatorcontrib>Chang, Chih-Hsien</creatorcontrib><collection>Docstoc</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The Journal of nuclear medicine (1978)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Ming-Hsin</au><au>Shiue, Chyng-Yann</au><au>Chang, Han-Chih</au><au>Feng, Chun-Fang</au><au>Chang, Chih-Hsien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice</atitle><jtitle>The Journal of nuclear medicine (1978)</jtitle><date>2017-05-01</date><risdate>2017</risdate><volume>58</volume><spage>1101</spage><pages>1101-</pages><issn>0161-5505</issn><eissn>1535-5667</eissn><abstract>Objectives: Histone deacetylases (HDACs) are considered viable drug targets for therapeutic applications including cancer and neurological disorders. Methods: In the present paper, the synthesis of 18F-labeled INER-1577-3 (a HDAC inhibitor which has shown in vitro and in vivo activity in HDAC1,2,3,6,8 protein and SAMR1/SAMP/8 rodent animal model) is described for the first time. The radio synthesis has been approached by reaction of the non-radioactive precursor N-(4-amino-[1,1'-biphenyl]-3-yl)-4-((dimethylamino)methyl)benzamide with [18F] flouride in basic media. Results: Despite the presence of more than one reactive site in the chemical structure of the precursor, acceptable radiochemical yield (3%, decay corrected to the end of bombardment), specific activity ( 100±25 μCi/ 100μL ) and radio chemical purity values (95%) were obtained in reasonably short preparation times(40 min). Conclusion: Despite the moderate radio chemical yield, final radioactivity and radioactivity concentration values (1.870.3GBq and 180MBq/ml, respectively) should be sufficient for putative in vivo studies in animals.</abstract><cop>New York</cop><pub>Society of Nuclear Medicine</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0161-5505 |
ispartof | The Journal of nuclear medicine (1978), 2017-05, Vol.58, p.1101 |
issn | 0161-5505 1535-5667 |
language | eng |
recordid | cdi_proquest_journals_2039865117 |
source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Benzamide Biphenyl Bombardment Cancer Chemical synthesis Histone deacetylase In vivo methods and tests Neurological diseases Neurological disorders Nuclear medicine Organic chemistry Precursors Proteins Radioactivity Radiochemistry Therapeutic applications |
title | Synthesis and evaluation of F-18-INER-1577 as HDACi Imaging Agent in Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T14%3A15%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20evaluation%20of%20F-18-INER-1577%20as%20HDACi%20Imaging%20Agent%20in%20Mice&rft.jtitle=The%20Journal%20of%20nuclear%20medicine%20(1978)&rft.au=Li,%20Ming-Hsin&rft.date=2017-05-01&rft.volume=58&rft.spage=1101&rft.pages=1101-&rft.issn=0161-5505&rft.eissn=1535-5667&rft_id=info:doi/&rft_dat=%3Cproquest%3E2039865117%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2039865117&rft_id=info:pmid/&rfr_iscdi=true |